PIK3CA and neoplasm: In addition, activating mutations in downstream effectors such as KRAS and PIK3CA, as well as loss-of-function mutations in the tumor suppressor PTEN, can drive constitutive signaling independent of RTKs, further limiting the efficacy of FGFR inhibition.155